
BPH treatment patterns: Understanding regional differences in baseline ED treatment
Muhammed A. Moukhtar Hammad, MBBCh, MSc, discusses real-world trends in baseline erectile dysfunction treatment across AUA sections before minimally invasive BPH procedures.
In this video, Muhammed A. Moukhtar Hammad, MBBCh, MSc, a research fellow at the University of California, Irvine, discusses research examining real-world patterns in
Hammad explains that the study was motivated by a lack of large real-world analyses comparing sexual function outcomes across minimally invasive BPH procedures. Although postoperative urinary incontinence is an important consideration when evaluating these interventions, he notes that sexual function outcomes also warrant attention, particularly given the limited head-to-head evidence available to guide procedure selection.
To address this gap, the research team used the AUA AQUA Registry to characterize procedure utilization and establish a baseline understanding of patients' sexual-health treatment histories before examining procedure-specific outcomes. The analysis included 83,828 men who underwent selected BPH procedures between 2014 and 2024.
The initial findings showed that UroLift and Rezūm were the most commonly performed first procedures, accounting for 62.5% and 18.0% of the cohort, respectively. The researchers also identified regional differences in baseline erectile dysfunction (ED) treatment patterns, with the proportion of patients eligible for postoperative ED medication analyses varying across AUA sections. Baseline ED medication exposure before BPH intervention ranged from 76.4% of patients in the North Central section to 92.5% of patients in the Mid-Atlantic section. In contrast, more than 95% of patients across the sections had no history of penile prosthesis implantation before their BPH procedure.
Hammad emphasizes the importance of understanding these baseline differences before drawing conclusions about postoperative sexual function outcomes.
He explained, “From here, we have a solid cohort, and the next step is to look at procedure-specific differences as well as AUA section differences with regards to BPH procedures’ sexual function outcomes.”
REFERENCE
1. Hammad MAM, Roth B, Abou Chawareb E, et al. Minimally Invasive BPH Procedures Dominate Contemporary U.S. Practice, With Regional Variation in Erectile Dysfunction Treatment Cohorts Across AUA Sections: Initial Insights from the AUA AQUA Registry. Presented at: 27th Annual Fall Scientific Meeting of SMSNA. October 8-11, 2026. Orlando, Florida. Abstract 027
Related to this article








